Literature DB >> 6097190

Characterization of a phosphatidylinositol 4-phosphate-specific phosphomonoesterase in rat liver nuclear envelopes.

C D Smith, W W Wells.   

Abstract

Incubation of rat liver nuclear envelopes with [gamma-32P]ATP resulted in the synthesis of phosphatidylinositol-[4-32P]phosphate (PIP). Degradation of endogenously labeled PIP was observed upon the dilution of the labeled ATP with an excess of unlabeled ATP. This degradation was most rapid in the presence of EDTA, and was inhibited by MgCl2 and CaCl2. To further characterize the degradative activity, phosphatidylinositol[4-32P]phosphate and phosphatidylinositol [4,5-32P]bisphosphate (PIP2) were synthesized and isolated from erythrocyte plasma membranes. The 32P-labeled phospholipids were then resuspended in 0.4% Tween 80, a detergent that did not inhibit degradation of endogenously labeled PIP, and mixed with nuclear envelopes. [32P]PIP and [32P]PIP2 were degraded at rates of 2.25 and 0.04 nmol min-1 mg nuclear envelope protein-1, respectively. Only 32P was released from phosphatidyl[2-3H]inositol-[4-32P]phosphate, indicating that hydrolysis of PIP was due to a phosphomonoesterase activity (EC 3.1.3.36) in nuclear envelopes. Similarly, anion-exchange chromatographic analysis of the water-soluble products released from [32P]PIP indicated that inorganic phosphate was the sole 32P-labeled product. Hydrolysis of PIP was most rapid at neutral pH, and was not affected by inhibitors of acid phosphatase or alkaline phosphatase. Hydrolysis of PIP was also not inhibited by nonspecific phosphatase substrates, such as glycerophosphate, p-nitrophenylphosphate, AMP, or glucose 6-phosphate. Hydrolysis was stimulated by putrescine, and was inhibited by inositol 2-phosphate, spermidine, spermine, and neomycin.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6097190     DOI: 10.1016/0003-9861(84)90226-1

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  9 in total

1.  Synthesis of polyphosphoinositides in nuclei of Friend cells. Evidence for polyphosphoinositide metabolism inside the nucleus which changes with cell differentiation.

Authors:  L Cocco; R S Gilmour; A Ognibene; A J Letcher; F A Manzoli; R F Irvine
Journal:  Biochem J       Date:  1987-12-15       Impact factor: 3.857

2.  The formation of lysophosphatidylinositol phosphate in human platelet microsomes.

Authors:  L M Thomas; B J Holub
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

Review 3.  When PIP2 Meets p53: Nuclear Phosphoinositide Signaling in the DNA Damage Response.

Authors:  Yu-Hsiu Wang; Michael P Sheetz
Journal:  Front Cell Dev Biol       Date:  2022-05-13

4.  Polyamines and neomycin inhibit the purified plasma-membrane Ca2+ pump by interacting with associated polyphosphoinositides.

Authors:  L Missiaen; F Wuytack; L Raeymaekers; H De Smedt; R Casteels
Journal:  Biochem J       Date:  1989-08-01       Impact factor: 3.857

5.  Defective signal-transduction pathways in T-cells from autoimmune MRL-lpr/lpr mice are associated with increased polyamine concentrations.

Authors:  T J Thomas; U B Gunnia; J R Seibold; T Thomas
Journal:  Biochem J       Date:  1995-10-01       Impact factor: 3.857

6.  Polyamines inhibit phospholipase C-catalysed polyphosphoinositide hydrolysis. Studies with permeabilized GH3 cells.

Authors:  R J Wojcikiewicz; J N Fain
Journal:  Biochem J       Date:  1988-11-01       Impact factor: 3.857

7.  Modulation of inositol phospholipid metabolism by polyamines.

Authors:  C D Smith; R Snyderman
Journal:  Biochem J       Date:  1988-11-15       Impact factor: 3.857

8.  DNA damage causes rapid accumulation of phosphoinositides for ATR signaling.

Authors:  Yu-Hsiu Wang; Anushya Hariharan; Giulia Bastianello; Yusuke Toyama; G V Shivashankar; Marco Foiani; Michael P Sheetz
Journal:  Nat Commun       Date:  2017-12-14       Impact factor: 14.919

Review 9.  Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.

Authors:  Jie Xian; Eric Owusu Obeng; Stefano Ratti; Isabella Rusciano; Maria Vittoria Marvi; Antonietta Fazio; Alessia De Stefano; Sara Mongiorgi; Alessandra Cappellini; Giulia Ramazzotti; Lucia Manzoli; Lucio Cocco; Matilde Yung Follo
Journal:  Cells       Date:  2020-03-12       Impact factor: 6.600

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.